Nunzia Pharmaceutical Financials
| NUNZ Stock | USD 0 0.00 0.00% |
Nunzia |
Please note, the imprecision that can be found in Nunzia Pharmaceutical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Nunzia Pharmaceutical. Check Nunzia Pharmaceutical's Beneish M Score to see the likelihood of Nunzia Pharmaceutical's management manipulating its earnings.
Nunzia Pharmaceutical Stock Summary
Nunzia Pharmaceutical Company operates as a pharmaceutical and nutraceutical company. Nunzia Pharmaceutical Company was incorporated in 1986 and is based in Long Beach, California. Nunzia Pharmaceutical is traded on OTC Exchange in the United States.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 1627 West 14th |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.nunziapharma.com |
| Phone | 714 609 9117 |
| Currency | USD - US Dollar |
Nunzia Pharmaceutical Key Financial Ratios
Nunzia Pharmaceutical's financial ratios allow both analysts and investors to convert raw data from Nunzia Pharmaceutical's financial statements into concise, actionable information that can be used to evaluate the performance of Nunzia Pharmaceutical over time and compare it to other companies across industries.| Return On Asset | -2702.39 | |||
| Beta | -2.57 |
Nunzia Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nunzia Pharmaceutical's current stock value. Our valuation model uses many indicators to compare Nunzia Pharmaceutical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nunzia Pharmaceutical competition to find correlations between indicators driving Nunzia Pharmaceutical's intrinsic value. More Info.Nunzia Pharmaceutical is regarded second in return on asset category among its peers. It is rated top company in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Nunzia Pharmaceutical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Nunzia Pharmaceutical's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Nunzia Pharmaceutical Systematic Risk
Nunzia Pharmaceutical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Nunzia Pharmaceutical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Nunzia Pharmaceutical correlated with the market. If Beta is less than 0 Nunzia Pharmaceutical generally moves in the opposite direction as compared to the market. If Nunzia Pharmaceutical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Nunzia Pharmaceutical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Nunzia Pharmaceutical is generally in the same direction as the market. If Beta > 1 Nunzia Pharmaceutical moves generally in the same direction as, but more than the movement of the benchmark.
Additional Tools for Nunzia Pink Sheet Analysis
When running Nunzia Pharmaceutical's price analysis, check to measure Nunzia Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nunzia Pharmaceutical is operating at the current time. Most of Nunzia Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Nunzia Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nunzia Pharmaceutical's price. Additionally, you may evaluate how the addition of Nunzia Pharmaceutical to your portfolios can decrease your overall portfolio volatility.